[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100654056":3},{"organization":4,"outcomesModule":7,"designInfo":34,"detailedDescription":33,"studyPopulation":33,"armGroups":40,"interventions":50,"overallOfficials":66,"centralContacts":70,"locations":76,"responsibleParty":101,"collaborators":33,"id":103,"slug":104,"hasResults":105,"nctId":106,"briefTitle":107,"officialTitle":108,"acronym":109,"eligibilityCriteria":110,"healthyVolunteers":105,"sex":111,"minAge":112,"maxAge":113,"enrollmentInfo":114,"targetDuration":33,"studyType":117,"phases":118,"briefSummary":120,"conditions":121,"keywords":123,"overallStatus":79,"whyStopped":33,"lastUpdateSubmitDate":128,"lastUpdatePostDateStruct":129,"startDateStruct":132,"completionDateStruct":134,"leadSponsor":136,"locationsCount":137},{"fullName":5,"class":6},"AbbVie","INDUSTRY",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":33},[9],{"measure":10,"description":11,"timeFrame":12},"Percentage of Participants With Response of Satisfied or Very Satisfied on Appearance of Neck and Lower Face Questionnaire (ANLFQ): Satisfaction Follow-Up","The ANLFQ is a 5-point scale that assesses participant satisfaction. Response options range from Very satisfied to Very dissatisfied.","Day 104",[14,18,21,24,27,30],{"measure":15,"description":16,"timeFrame":17},"Change From Baseline in Participant's Rasch-transformed Score of the FACE-Q Psychological Function","The FACE-Q Psychological Function scale assesses the psychological impact of facial appearance. The Rasch-transformed summary score ranges from worst to best.","Up to approximately 104 days",{"measure":19,"description":20,"timeFrame":17},"Change From Baseline in Participant's Rasch-transformed Score of the FACE-Q Satisfaction With Lower Face and Jawline","FACE-Q Satisfaction assesses participant satisfaction with the appearance of their lower face and jawline. The Rasch-transformed summary score ranges from worst to best.",{"measure":22,"description":23,"timeFrame":17},"Change From Baseline in Participant's Rasch-transformed Score of the SKIN-Q - Skin Looks","SKIN-Q - Skin Looks assesses participant's satisfaction with how their skin looks. Rasch transformed scores ranges from worst to best.",{"measure":25,"description":26,"timeFrame":17},"Change From Baseline in Participant's Allergan Facial Confidence Scale (AFCS) - Confidence (Treatment Area) Total Score","AFCS - Confidence (Treatment Area) is a questionnaire that assesses the participant's confidence in the appearance of the treatment area. 4-point response option ranges from Very Confident to Not at all confident.",{"measure":28,"description":29,"timeFrame":17},"Percentage of Participants With Response of Improved or Much Improved on Investigator Global Aesthetic Improvement Scale (GAIS)","GAIS is a clinician-rated 5-point scale that assesses of overall aesthetic improvement compared to baseline. Scores range from \"Much improved\" to \"Much worse\".",{"measure":31,"description":32,"timeFrame":17},"Percentage of Participants With Response of Satisfied or Very Satisfied (or Agree or Definitely Agree) on Allergan Facial Satisfaction Scale (AFSS) - Natural Look and Feel","AFSS assesses participant satisfaction. Scores range from \"Very satisfied\" to\" Very dissatisfied\".",null,{"allocation":35,"interventionModel":36,"interventionModelDescription":33,"primaryPurpose":37,"observationalModel":33,"timePerspective":33,"maskingInfo":38},"NA","SINGLE_GROUP","TREATMENT",{"masking":39,"maskingDescription":33,"whoMasked":33},"NONE",[41],{"label":42,"type":43,"description":44,"interventionNames":45},"JUVÉDERM Products Plus OnabotulinumtoxinA","EXPERIMENTAL","Participants in the study will receive the products in the jaw area, chin, and neck.",[46,47,48,49],"Drug: OnabotulinumtoxinA","Device: SKINVIVE","Device: VOLUX","Device: VOLUMA",[51,56,60,63],{"type":52,"name":53,"description":54,"armGroupLabels":55,"otherNames":33},"DRUG","OnabotulinumtoxinA","Injection",[42],{"type":57,"name":58,"description":54,"armGroupLabels":59,"otherNames":33},"DEVICE","SKINVIVE",[42],{"type":57,"name":61,"description":54,"armGroupLabels":62,"otherNames":33},"VOLUX",[42],{"type":57,"name":64,"description":54,"armGroupLabels":65,"otherNames":33},"VOLUMA",[42],[67],{"name":68,"affiliation":5,"role":69},"ABBVIE INC.","STUDY_DIRECTOR",[71],{"name":72,"role":73,"phone":74,"phoneExt":33,"email":75},"ABBVIE CALL CENTER","CONTACT","844-663-3742","abbvieclinicaltrials@abbvie.com",[77,91],{"facility":78,"status":79,"city":80,"state":81,"zip":82,"country":83,"countryCode":84,"cosmosGeoPoint":85,"geoPoint":90,"contacts":33},"Humphrey & Beleznay Cosmetic Dermatology \u002FID# 282598","RECRUITING","Vancouver","British Columbia","V5Z 4E1","Canada","CA",{"type":86,"coordinates":87},"Point",[88,89],-123.11934,49.24966,{"lat":89,"lon":88},{"facility":92,"status":79,"city":93,"state":94,"zip":95,"country":83,"countryCode":84,"cosmosGeoPoint":96,"geoPoint":100,"contacts":33},"Sweat Clinics Of Canada \u002FID# 281845","Toronto","Ontario","M5R 3N8",{"type":86,"coordinates":97},[98,99],-79.39864,43.70643,{"lat":99,"lon":98},{"type":102,"investigatorFullName":33,"investigatorTitle":33,"investigatorAffiliation":33,"oldNameTitle":33,"oldOrganization":33},"SPONSOR","100654056","phase-4-study-to-assess-participant-satisfaction-after-jawline-and-neck-treatment-100654056",false,"NCT07794891","Study to Assess Participant Satisfaction After Jawline and Neck Treatment","A Prospective, Open-label Study to Evaluate Subject Satisfaction and Psychosocial Outcomes After Treatment of Jawline and Neck With BOTOX® Cosmetic and JUVÉDERM® Products","AURA","Inclusion Criteria:\n\n* Moderate or severe transverse neck lines based on investigator's live assessment\n* Moderate or severe loss of jawline definition based on investigator's live assessment.\n* Moderate or severe platysma prominence based on investigator's live assessment.\n\nExclusion Criteria:\n\n* History of or current medical condition that may put the subject at increased medical risk with exposure to BOTOX, or any other condition that might interfere with neuromuscular function.\n* History of or current symptoms of dysphagia.\n* History of severe allergies manifested by a history of anaphylaxis or history or presence of multiple severe allergies.\n* History of hypersensitivity or allergy to any botulinum toxin serotype, Streptococcal or gram-positive bacterial proteins, lidocaine, HA products, any other excipients or constituents of the study drug, device, and\u002For other products in the same class.\n* History of or tendency for keloid formation, hyperpigmentation, or hypertrophic scarring.","ALL","22 Years","65 Years",{"count":115,"type":116},100,"ESTIMATED","INTERVENTIONAL",[119],"PHASE4","The goal of this study is to evaluate overall participant satisfaction with the jawline and neck.\n\nParticipants will receive select Juvéderm products and onabotulinumtoxinA in the jaw area and neck per eligibility criteria.\n\nThe study will measure changes in psychological function, satisfaction with lower face and jawline and skin appearance. Participants will attend visits during the study at a clinical site. The effects of the treatment will be checked by medical assessments, vital signs, physical examinations, checking for side effects, and completing questionnaires.",[122],"Jawline and Neck Appearance",[124,125,126,127],"AURA Study","Jaw area and Neck Appearance","onabotulinumtoxinA","JUVÉDERM","2026-10-06",{"date":130,"type":131},"2026-10-08","ACTUAL",{"date":133,"type":131},"2026-09-09",{"date":135,"type":116},"2027-06",{"name":5,"class":6},2]